DE60232496D1 - Tabletten, die in der mundhöhle schnell zerfallen - Google Patents

Tabletten, die in der mundhöhle schnell zerfallen

Info

Publication number
DE60232496D1
DE60232496D1 DE60232496T DE60232496T DE60232496D1 DE 60232496 D1 DE60232496 D1 DE 60232496D1 DE 60232496 T DE60232496 T DE 60232496T DE 60232496 T DE60232496 T DE 60232496T DE 60232496 D1 DE60232496 D1 DE 60232496D1
Authority
DE
Germany
Prior art keywords
mouthhouse
falling fast
tablets falling
water
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60232496T
Other languages
English (en)
Inventor
Motohiro Ohta
Muneko Kuboyama
Hirokazu Yoshimoto
Yasushi Watanabe
Kiyoshi Morimoto
Makoto Kosugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18921782&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60232496(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd
Application granted granted Critical
Publication of DE60232496D1 publication Critical patent/DE60232496D1/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
DE60232496T 2001-03-06 2002-03-05 Tabletten, die in der mundhöhle schnell zerfallen Revoked DE60232496D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001062678 2001-03-06
PCT/JP2002/002048 WO2002069933A1 (fr) 2001-03-06 2002-03-05 Comprimés à délitement rapide dans la bouche

Publications (1)

Publication Number Publication Date
DE60232496D1 true DE60232496D1 (de) 2009-07-16

Family

ID=18921782

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60232496T Revoked DE60232496D1 (de) 2001-03-06 2002-03-05 Tabletten, die in der mundhöhle schnell zerfallen

Country Status (12)

Country Link
US (1) US20040122106A1 (de)
EP (1) EP1366759B1 (de)
JP (1) JP4365095B2 (de)
KR (1) KR20030094272A (de)
CN (1) CN1239151C (de)
AT (1) ATE432692T1 (de)
AU (1) AU2002237548B2 (de)
CA (1) CA2439873A1 (de)
DE (1) DE60232496D1 (de)
ES (1) ES2325484T3 (de)
RU (1) RU2003129506A (de)
WO (1) WO2002069933A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
JP4551627B2 (ja) * 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
JP5584509B2 (ja) * 2003-02-28 2014-09-03 東和薬品株式会社 口腔内崩壊錠剤
EP1709975A1 (de) * 2003-07-10 2006-10-11 Kyowa Hakko Kogyo Co., Ltd. Tablette und herstellungsverfahren dafür
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
JP4547161B2 (ja) * 2004-01-22 2010-09-22 エスエス製薬株式会社 用時溶解型速溶性固形製剤
GB0408078D0 (en) * 2004-04-08 2004-05-12 Novartis Ag Organic compounds
JP5208348B2 (ja) * 2004-05-13 2013-06-12 旭化成ファーマ株式会社 ナフトピジルを含有する医薬
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US7820198B2 (en) * 2004-10-19 2010-10-26 Arch Chemicals, Inc. Pool chemical tablet
IL164679A0 (en) * 2004-10-19 2005-12-18 Rafi Bronstein Scitex Vision L A method of inkjet printing with image quality control
WO2006047493A2 (en) 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US8883121B2 (en) * 2005-07-25 2014-11-11 Otsuka Pharmaceutical Co., Ltd. Oral preparation useful in measurement capacity to metabolize pyridine
JP5100391B2 (ja) * 2005-10-05 2012-12-19 京都薬品工業株式会社 経口用組成物
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
WO2008120548A2 (ja) * 2007-03-13 2008-10-09 Dainippon Sumitomo Pharma Co., Ltd. 口腔内崩壊錠
EP2214679B1 (de) 2007-11-13 2019-03-27 Meritage Pharma, Inc. Kortikosteroidzusammensetzungen
EP2385769A4 (de) * 2008-12-15 2014-08-20 Valeant Pharmaceuticals Luxembourg S R L Schnell lösliche vitaminformulierung und verfahren zu ihrer anwendung
CA2765033C (en) 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CN108159019A (zh) 2009-12-02 2018-06-15 阿黛尔药物有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
US20110212171A1 (en) * 2010-01-08 2011-09-01 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
JP4803686B2 (ja) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
JP5280420B2 (ja) * 2010-10-18 2013-09-04 旭化成ファーマ株式会社 ナフトピジルを含有する医薬の製造方法
WO2012075455A2 (en) 2010-12-02 2012-06-07 Aptalis Pharmatech, Inc. Rapidly dispersing granules, orally disintegrating tablets and methods
JP6004882B2 (ja) * 2012-10-15 2016-10-12 三菱商事フードテック株式会社 圧縮成形に用いるためのマンニトール賦形剤及びこれを含有する錠剤
US20140179655A1 (en) * 2012-12-20 2014-06-26 Solural Pharma ApS Solid oral dosage form of testosterone derivative
CN104645336B (zh) * 2015-01-04 2017-08-29 深圳市药品检验研究院 一种复合辅料及其制备方法和用途
CN104770543A (zh) * 2015-04-20 2015-07-15 王永帮 一种砂型奶糖用矫味剂
CN104824310A (zh) * 2015-04-20 2015-08-12 王永帮 一种无异味的砂型奶糖
EP3720418B1 (de) * 2017-12-08 2021-08-04 Fertin Pharma A/S Nikotintablette
JP7094563B2 (ja) * 2019-08-05 2022-07-04 学校法人松山大学 錠剤及びその製造方法並びに打錠用粉末
AU2022331315A1 (en) * 2021-08-19 2024-02-22 Mind Medicine, Inc. Lyophilized orally disintegrating tablet formulations of d-lysergic acid diethylamide for therapeutic applications

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6185330A (ja) * 1984-10-04 1986-04-30 Fuji Kagaku Kogyo Kk 直打用賦形薬の製造法
WO1987001936A1 (en) * 1985-09-25 1987-04-09 Gerhard Gergely Desintegration tablet and process for its manufacture
EP0429832B1 (de) * 1989-11-30 1994-06-22 PCD-Polymere Gesellschaft m.b.H. Nicht wirkstoffretardierender Pressling, Verfahren zu dessen Herstellung und Verwendung von Polyhydroxybuttersäure zur Herstellung eines solchen Presslings
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
FR2710637B1 (fr) * 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
DE69733476T2 (de) * 1996-06-14 2006-03-23 Kyowa Hakko Kogyo Co., Ltd. Im munde schnellzerfallende tablette
DE69732909T2 (de) * 1996-07-12 2005-08-11 Daiichi Pharmaceutical Co., Ltd. Rasch zerfallende Pressmasse und Verfahren zu ihrer Herstellung
JP3296412B2 (ja) * 1997-04-25 2002-07-02 田辺製薬株式会社 成型製剤及びその製法
JP4196417B2 (ja) * 1997-06-27 2008-12-17 大正製薬株式会社 口腔内速崩錠及びその製造方法
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
JPH11169437A (ja) * 1997-12-03 1999-06-29 Kyowa Hakko Kogyo Co Ltd 錠剤の製造方法
US6365182B1 (en) * 1998-08-12 2002-04-02 Cima Labs Inc. Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
CA2346350C (en) * 1998-10-05 2008-01-08 Eisai Co., Ltd. Intraoral quickly disintegrating tablets
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
WO2000078292A1 (fr) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Preparations solides a desintegration rapide
PT1260215E (pt) * 2000-03-01 2009-09-03 Eisai R&D Man Co Ltd Comprimido de desintegração rápida que contém poli(álcool vinílico)

Also Published As

Publication number Publication date
EP1366759A1 (de) 2003-12-03
JP4365095B2 (ja) 2009-11-18
AU2002237548B2 (en) 2007-04-05
US20040122106A1 (en) 2004-06-24
RU2003129506A (ru) 2005-03-10
KR20030094272A (ko) 2003-12-11
CN1494418A (zh) 2004-05-05
WO2002069933A1 (fr) 2002-09-12
ATE432692T1 (de) 2009-06-15
JPWO2002069933A1 (ja) 2004-07-02
CN1239151C (zh) 2006-02-01
EP1366759B1 (de) 2009-06-03
CA2439873A1 (en) 2002-09-12
ES2325484T3 (es) 2009-09-07
EP1366759A4 (de) 2006-04-19

Similar Documents

Publication Publication Date Title
DE60232496D1 (de) Tabletten, die in der mundhöhle schnell zerfallen
ATE333265T1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
HRP20030951B1 (hr) Formulacije jednodnevnih doza oksikodona
ATE516017T1 (de) Feste pharmazeutische dosierform enthaltende ritonavir
HUP0402293A2 (hu) Fexofenadint tartalmazó szájban diszpergálódó tablettakészítmény, bevonatos granulátum és eljárás az előállítására
ITMI20001173A0 (it) Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva.
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
ATE445597T1 (de) ß2-OXO-1-PYRROLIDINDERIVATE UND IHRE PHARMAZEUTISCHE VERWENDUNGß
ECSP055568A (es) Composición de comprimido de liberación sostenida de pramipexol
DK1121103T3 (da) Oralt disintegrerbare tabletter, der omfatter en benzimidazol
CA2273420A1 (fr) Comprime matriciel permettant la liberation prolongee de gliclazide apres administration par voie orale
RS49611B (sr) Ziprasidon formulacije
DE60117289D1 (de) Schnelllösliche tabletten
MXPA03006476A (es) Composiciones farmaceuticas, formas de dosificacion y metodos para administracion oral de epotilonas.
DK1113787T3 (da) Agitationsuafhængige farmaceutiske multipelenhedsretardformuleringer og fremgangsmåde til deres fremstilling
EA200401397A1 (ru) Композиции-ингибиторы циклооксигеназы-2, содержащие 2-(3,5-дифторфенил)-3-[4-(метилсульфонил)фенил]-2-циклопентен-1-он или (s)-6,8-дихлор-2-(трифторметил)-2h-1-бензопиран-3-карбоновую кислоту
NO20026123D0 (no) Farmasöytiske sammensetninger
NO20010863L (no) Nye orale formuleringer for 5-HT4-agonister eller - antagonister
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
ATE442158T1 (de) Oral verabreichte pharmazeutische zusammensetzungen mit einem abgabemittel in mikronisierter form
MA27262A1 (fr) Microcapsules pour la liberation retardee et controlee du perindopril
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
BR0010521A (pt) Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação
AU2002358819A1 (en) Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
AR045724A1 (es) Composicion farmaceutica orodispersable de un compuesto antitrombotico

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation